MCL1 and lung adenocarcinoma: Despite data that Mcl-1 expression does not correlate with response to Mcl-1 inhibition [26], in lung adenocarcinoma patients Mcl-1 expression can be additional risk stratification factor which might help identifying patients with worse prognosis who would benefit more from Mcl-1 inhibition.